Araştırma Makalesi

Thymoquinone reduces methotrexate-induced heart damage: a histopathological study in rats

Cilt: 48 Sayı: 3 30 Eylül 2023
PDF İndir
TR EN

Thymoquinone reduces methotrexate-induced heart damage: a histopathological study in rats

Öz

Purpose: The study aimed to evaluate the effect of thymoquinone on cardiac tissue in MTX-induced cardiac toxicity in rats with various parameters. Materials and Methods: Group I (n:8) was administered intraperitoneal saline for 10 days. Intraperitoneal olive oil was applied to Group II (n:8) for 10 days. Group III (n:8) was administered a single dose of 20 mg/kg Methotrexate (MTX) (500 mg/20 ml) intraperitoneally on the 1st day of the experiment. Since Methotrexate was in liquid form, no solvent was used. Group IV (n:8) received 10 mg/kg Thymoquinone (THQ) intraperitoneally for 10 days. Group V (n:8) (MTX: (20 mg/kg single dose intraperitoneally on the 1st day); THQ: 10mg/kg i.p. administered for 10 days. At the end of the experimental period, the rats were sacrificed for analysis of heart tissue. The structure of heart tissue was evaluated by haematoxylin-eosin staining. Immunohistochemically, connexin-43, HSP90, and HIF-1α antibodies were stained. The results were analysed statistically. Results: According to our results, thymoquinone has a positive effect on the expression of Cx43, one of the proteins providing transmission in the intercalary discs, HSP90, one of the chaperones in the cell, and HIF-1α expression against MTX toxicity and provides a significant improvement by showing a cardioprotective effect histopathologically. Conclusion: THQ could be considered a crucial cardioprotective phytochemical against MTX cardiotoxicity.

Anahtar Kelimeler

Key words: Conneksin-43, HIF-1α, HSP90, Methotrexate, Thymoquinone

Destekleyen Kurum

Yozgat Bozok Üniversitesi BAP

Proje Numarası

21/036

Kaynakça

  1. Genestier L, Paillot R, Quemeneur L, Izeradjene K, Revillard JP. Mechanisms of action of methotrexate. Immunopharmacology. 2000;47:247-57.
  2. Perez-Verdia A, Angulo F, Hardwicke FL, Nugent KM. Acute cardiac toxicity associated with high-dose intravenous methotrexate therapy: case report and review of the literature. Pharmacother J Hum Pharmacol Drug Ther. 2005;25:1271-6.
  3. Al-Taher AY, Morsy MA, Rifaai RA, Zenhom NM, Abdel-Gaber SA. Paeonol attenuates methotrexate-induced cardiac toxicity in rats by inhibiting oxidative stress and suppressing TLR4-induced NF-κB inflammatory pathway. Mediators Inflamm. 2020;2020:8641026.
  4. Abdel-Daim MM, Khalifa HA, Abushouk AI, Dkhil MA, Al-Quraishy SA. Diosmin attenuates methotrexate-induced hepatic, renal, and cardiac injury: a biochemical and histopathological study in mice. Oxid Med Cell Longev. 2017;2017:3281670.
  5. Johnson RD, Camelliti P. Role of non-myocyte gap junctions and connexin hemichannels in cardiovascular health and disease: novel therapeutic targets? Int J Mol Sci. 2018;19:866.
  6. Severs NJ, Bruce AF, Dupont E, Rothery S. Remodelling of gap junctions and connexin expression in diseased myocardium. Cardiovasc Res. 2008;80:9-19.
  7. Ko YS, Yeh HI, Ko YL, Hsu YC, Chen CF, Wu S et al. Three-dimensional reconstruction of the rabbit atrioventricular conduction axis by combining histological, desmin, and connexin mapping data. Circulation. 2004;109:1172-9.
  8. Desplantez T. Cardiac Cx43, Cx40 and Cx45 co-assembling: Involvement of connexins epitopes in formation of hemichannels and Gap junction channels. BMC Cell Biol. 2017;18:1-13.
  9. Yu X, Mao M, Liu X, Shen T, Li T, Yu H et al. A cytosolic heat shock protein 90 and co-chaperone p23 complex activates RIPK3/MLKL during necroptosis of endothelial cells in acute respiratory distress syndrome. J Mol Med. 2020;98:569-83.
  10. Minet E, Mottet D, Michel G, Roland I, Raes M, Remacle J et al. Hypoxia-induced activation of HIF-1: role of HIF-1α-Hsp90 interaction. FEBS Lett. 1999;460:251-6.

Kaynak Göster

APA
Yıldırım, A. B., Kaymak, E., Ceylan, T., Akın, A., Kuloğlu, N., Sayan, M., Değer, N., Önal, E., & Karabulut, D. (2023). Thymoquinone reduces methotrexate-induced heart damage: a histopathological study in rats. Cukurova Medical Journal, 48(3), 844-851. https://doi.org/10.17826/cumj.1314101
AMA
1.Yıldırım AB, Kaymak E, Ceylan T, vd. Thymoquinone reduces methotrexate-induced heart damage: a histopathological study in rats. Cukurova Med J. 2023;48(3):844-851. doi:10.17826/cumj.1314101
Chicago
Yıldırım, Ayşegül Burçin, Emin Kaymak, Tayfun Ceylan, vd. 2023. “Thymoquinone reduces methotrexate-induced heart damage: a histopathological study in rats”. Cukurova Medical Journal 48 (3): 844-51. https://doi.org/10.17826/cumj.1314101.
EndNote
Yıldırım AB, Kaymak E, Ceylan T, Akın A, Kuloğlu N, Sayan M, Değer N, Önal E, Karabulut D (01 Eylül 2023) Thymoquinone reduces methotrexate-induced heart damage: a histopathological study in rats. Cukurova Medical Journal 48 3 844–851.
IEEE
[1]A. B. Yıldırım vd., “Thymoquinone reduces methotrexate-induced heart damage: a histopathological study in rats”, Cukurova Med J, c. 48, sy 3, ss. 844–851, Eyl. 2023, doi: 10.17826/cumj.1314101.
ISNAD
Yıldırım, Ayşegül Burçin - Kaymak, Emin - Ceylan, Tayfun - Akın, Ali - Kuloğlu, Nurhan - Sayan, Meryem - Değer, Necla - Önal, Esra - Karabulut, Derya. “Thymoquinone reduces methotrexate-induced heart damage: a histopathological study in rats”. Cukurova Medical Journal 48/3 (01 Eylül 2023): 844-851. https://doi.org/10.17826/cumj.1314101.
JAMA
1.Yıldırım AB, Kaymak E, Ceylan T, Akın A, Kuloğlu N, Sayan M, Değer N, Önal E, Karabulut D. Thymoquinone reduces methotrexate-induced heart damage: a histopathological study in rats. Cukurova Med J. 2023;48:844–851.
MLA
Yıldırım, Ayşegül Burçin, vd. “Thymoquinone reduces methotrexate-induced heart damage: a histopathological study in rats”. Cukurova Medical Journal, c. 48, sy 3, Eylül 2023, ss. 844-51, doi:10.17826/cumj.1314101.
Vancouver
1.Ayşegül Burçin Yıldırım, Emin Kaymak, Tayfun Ceylan, Ali Akın, Nurhan Kuloğlu, Meryem Sayan, Necla Değer, Esra Önal, Derya Karabulut. Thymoquinone reduces methotrexate-induced heart damage: a histopathological study in rats. Cukurova Med J. 01 Eylül 2023;48(3):844-51. doi:10.17826/cumj.1314101